ArticleClinical and translational radiation oncology2018

Anti PD-L1 DUrvalumab combined with Cetuximab and RadiOtherapy in locally advanced squamous cell carcinoma of the head and neck: A phase I/II study (DUCRO).

Pierluigi Bonomo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.